Literature DB >> 20036111

An aqueous extract of Ammi visnaga fruits and its constituents khellin and visnagin prevent cell damage caused by oxalate in renal epithelial cells.

P Vanachayangkul1, K Byer, S Khan, V Butterweck.   

Abstract

Teas prepared from the fruits of Ammi visnaga L. (syn. "Khella") have been traditionally used in Egypt as a remedy to treat kidney stones. It was the aim of our study to evaluate the effect of a Khella extract (KE) as well as the two major constituents khellin and visnagin on renal epithelial injury using LLC-PK1 and Madin-Darby-canine kidney (MDCK) cells. Both cell lines provide suitable model systems to study cellular processes that are possibly involved in the development of a renal stone. LLC-PK1 and MDCK cell lines were exposed to 300 microM oxalate (Ox) or 133 microg/cm(2) calcium oxalate monohydrate (COM) in presence or absence of 10, 50, 100 or 200 microg/mL KE. To evaluate cell damage, cell viability was assessed by determining the release of lactate dehydrogenase (LDH). KE (e.g. 100 microg/ml) significantly decreased LDH release from LLC-PK1 (Ox: 8.46+0.76%; Ox + 100 microg/ml KE: 5.41+0.94%, p<0.001) as well as MDCK cells (Ox: 30.9+6.58%; Ox+100 microg/ml KE: 17.5+2.50%, p<0.001), which indicated a prevention of cell damage. Similar effects for KE were observed in both cell lines when COM crystals were added. In LLC-PK1 cells khellin and visnagin both decreased the % LDH release significantly in cells that were pretreated with Ox or COM crystals. However, khellin and visnagin exhibited different responses in MDCK cells. Whereas khellin slightly reduced the % LDH release after exposure of the cells to Ox and COM crystals, visnagin significantly decreased % LDH release only after COM crystal exposure. Overall both compounds were more active in LLC-PK1 than in MDCK cells. In summary, exposure of renal epithelial cells to Ox or COM crystals was associated with a significant release of LDH indicating cell injury. Our data demonstrate that KE as well as khellin and visnagin could prevent renal epithelial cell damage caused by Ox and COM and could therefore play a potential role in the prevention of stone formation associated with hyperoxaluria. (c) 2009 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20036111      PMCID: PMC3618668          DOI: 10.1016/j.phymed.2009.10.011

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  33 in total

1.  Cell injury associated calcium oxalate crystalluria.

Authors:  R L Hackett; P N Shevock; S R Khan
Journal:  J Urol       Date:  1990-12       Impact factor: 7.450

2.  Renal cell cultures: a tool for studying tubular function and nephrotoxicity.

Authors:  G Gstraunthaler; D Steinmassl; W Pfaller
Journal:  Toxicol Lett       Date:  1990-09       Impact factor: 4.372

3.  Medical-expulsive therapy for distal ureterolithiasis: randomized prospective study on role of corticosteroids used in combination with tamsulosin-simplified treatment regimen and health-related quality of life.

Authors:  Marco Dellabella; Giulio Milanese; Giovanni Muzzonigro
Journal:  Urology       Date:  2005-10       Impact factor: 2.649

Review 4.  Kidney stone disease.

Authors:  Fredric L Coe; Andrew Evan; Elaine Worcester
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

5.  Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies.

Authors:  S Thamilselvan; S R Khan
Journal:  J Nephrol       Date:  1998 Mar-Apr       Impact factor: 3.902

6.  Oxalate is toxic to renal tubular cells only at supraphysiologic concentrations.

Authors:  Marieke S J Schepers; Eddy S van Ballegooijen; Chris H Bangma; Carl F Verkoelen
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

7.  Crystals cause acute necrotic cell death in renal proximal tubule cells, but not in collecting tubule cells.

Authors:  Marieke S J Schepers; Eddy S van Ballegooijen; Chris H Bangma; Carl F Verkoelen
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

Review 8.  Cell cultures and nephrolithiasis.

Authors:  C F Verkoelen; B G van der Boom; F H Schröder; J C Romijn
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

9.  Activation of c-myc gene mediates the mitogenic effects of oxalate in LLC-PK1 cells, a line of renal epithelial cells.

Authors:  H Koul; L Kennington; T Honeyman; J Jonassen; M Menon; C Scheid
Journal:  Kidney Int       Date:  1996-11       Impact factor: 10.612

10.  Oxalate toxicity in LLC-PK1 cells, a line of renal epithelial cells.

Authors:  C Scheid; H Koul; W A Hill; J Luber-Narod; J Jonassen; T Honeyman; L Kennington; R Kohli; J Hodapp; P Ayvazian; M Menon
Journal:  J Urol       Date:  1996-03       Impact factor: 7.450

View more
  20 in total

1.  Molecular mechanisms involved in the protective effect of the chloroform extract of Selaginella lepidophylla (Hook. et Grev.) Spring in a lithiasic rat model.

Authors:  Estévez-Carmona María Mirian; Narvaéz-Morales Juanita; Barbier Olivier Christophe; Meléndez-Camargo María Estela
Journal:  Urolithiasis       Date:  2013-03-30       Impact factor: 3.436

Review 2.  Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease.

Authors:  Robert H Glew; Yijuan Sun; Bruce L Horowitz; Konstantin N Konstantinov; Marc Barry; Joanna R Fair; Larry Massie; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2014-11-06

3.  Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase.

Authors:  Yan Liu; Aarti Asnani; Lin Zou; Victoria L Bentley; Min Yu; You Wang; Graham Dellaire; Kumar S Sarkar; Matthew Dai; Howard H Chen; David E Sosnovik; Jordan T Shin; Daniel A Haber; Jason N Berman; Wei Chao; Randall T Peterson
Journal:  Sci Transl Med       Date:  2014-12-10       Impact factor: 17.956

4.  Prevention of renal crystal deposition by an extract of Ammi visnaga L. and its constituents khellin and visnagin in hyperoxaluric rats.

Authors:  P Vanachayangkul; N Chow; S R Khan; Veronika Butterweck
Journal:  Urol Res       Date:  2010-11-11

5.  Total flavonoids of Desmodium styracifolium attenuates the formation of hydroxy-L-proline-induced calcium oxalate urolithiasis in rats.

Authors:  Jianfu Zhou; Jing Jin; Xiong Li; Zhongxiang Zhao; Lei Zhang; Qian Wang; Jing Li; Qiuhong Zhang; Songtao Xiang
Journal:  Urolithiasis       Date:  2017-05-31       Impact factor: 3.436

6.  Antioxidant properties of polysaccharide from the brown seaweed Sargassum graminifolium (Turn.), and its effects on calcium oxalate crystallization.

Authors:  Chao-Yan Zhang; Wen-Hui Wu; Jue Wang; Min-Bo Lan
Journal:  Mar Drugs       Date:  2012-01-16       Impact factor: 6.085

7.  Ammi Visnaga in treatment of urolithiasis and hypertriglyceridemia.

Authors:  Akshaya Srikanth Bhagavathula; Ahed Jumah Mahmoud Al-Khatib; Asim Ahmed Elnour; Naama M S Al Kalbani; Abdulla Shehab
Journal:  Pharmacognosy Res       Date:  2014 Oct-Dec

8.  The role of herbal medicines in treatment of urinary tract diseases.

Authors:  Ahmad-Reza Gohari; Soodabeh Saeidnia
Journal:  J Nephropharmacol       Date:  2014-01-01

Review 9.  Effective Medicinal Plant in Cancer Treatment, Part 2: Review Study.

Authors:  Wesam Kooti; Karo Servatyari; Masoud Behzadifar; Majid Asadi-Samani; Fatemeh Sadeghi; Bijan Nouri; Hadi Zare Marzouni
Journal:  J Evid Based Complementary Altern Med       Date:  2017-03-31

10.  The predictive utility of the plant phylogeny in identifying sources of cardiovascular drugs.

Authors:  Emily Guzman; Jeanmaire Molina
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.